Wheezing
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
132
|
54
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Well Differentiated Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
270
|
22
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Venous Thromboembolism
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
378
|
408
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Vascular lesions
|
disease |
|
Disease or Syndrome
|
111
|
9
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Vascular inflammations
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
305
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Vascular endothelial growth factor overexpression
|
disease |
|
Disease or Syndrome
|
26
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Urothelial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
449
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Urinary tract infection
|
group |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
219
|
14
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Ulcerative Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1458
|
827
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.060 |
None |
1.000 |
6 |
|
2013 |
2020 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Tumor Immunity
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
337
|
2
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Tumor Expansion
|
phenotype |
|
Neoplastic Process
|
46
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
1.000 |
13 |
1
|
2005 |
2019 |
Tumor Angiogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
822
|
5
|
0.070 |
None |
1.000 |
7 |
|
2011 |
2020 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Transitional cell carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
333
|
158
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Thromboembolic stroke
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
13
|
1
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Thrombocythemia, Essential
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
220
|
37
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Tauopathies
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
245
|
43
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Takayasu Arteritis
|
disease |
Skin and Connective Tissue Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
136
|
55
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Systemic Scleroderma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
979
|
287
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Systemic Inflammatory Response Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
185
|
9
|
0.010 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Synovitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
197
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |